MNPR earnings
Monopar Therapeutics (MNPR) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
MNPR earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | -0.62 | -0.64 | 3.64% | – |
| Q1 2026 | May 14, 2026 | -0.46 | -1.06 | 56.60% | – |
| Q4 2025 | Mar 27, 2026 | -0.61 | -0.51 | -19.08% | – |
| Q3 2025 | Nov 13, 2025 | -0.48 | -0.46 | -4.35% | – |
| Q2 2025 | Aug 12, 2025 | -0.35 | -0.47 | 25.53% | – |
| Q1 2025 | May 13, 2025 | -0.38 | -0.65 | 41.54% | – |
| Q4 2024 | Mar 31, 2025 | -2.23 | -0.36 | -519.44% | – |
| Q3 2024 | Nov 8, 2024 | -0.37 | -0.46 | 19.57% | – |
| Q2 2024 | Aug 9, 2024 | -0.50 | -0.45 | -11.11% | – |
| Q1 2024 | May 9, 2024 | -0.50 | -0.85 | 41.18% | – |
| Q4 2023 | Mar 28, 2024 | -0.60 | -0.85 | 29.41% | – |
| Q3 2023 | Nov 9, 2023 | -0.70 | -0.95 | 26.32% | – |
| Aug 10, 2023 | -0.80 | -0.95 | 15.79% | – | |
| May 11, 2023 | -0.95 | -1.00 | 5.00% | – | |
| Mar 23, 2023 | -1.10 | -1.05 | -4.76% | – | |
| Nov 10, 2022 | -0.95 | -1.15 | 17.39% | – | |
| Aug 11, 2022 | -0.22 | -0.21 | -4.76% | – | |
| May 12, 2022 | -0.95 | -1.20 | 20.83% | – | |
| Mar 24, 2022 | -0.21 | -0.19 | -8.25% | – | |
| Nov 12, 2021 | -1.00 | -1.10 | 9.09% | – |
- MNPR reports next on Nov 12, 2026, with EPS of -0.89 expected.
- MNPR beat EPS estimates in 16 of its last 27 reports.
Updated 2026-11-02 17:54 UTC